ACXP   $2.05  4.06% Market Closed

Acurx Pharmaceuticals Inc
Total Cash 6.36M
totalCashPerShare 0.392
EBITDA
Total Debt 0.00
quickRatio 2.034
currentRatio 2.087
Total Revenue
debtToEquity
Revenue/Share
ROA -1.3221699
ROE -3.46942
grossProfits
freeCashflow -5.96M
operatingCashflow -12.23M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 26.78M
forwardPE -1.2967743
floatShares 13.84M
sharesOutstanding 16.25M
sharesShort 452.82K
sharesShortPriorMonth 464.31K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.15%
heldPercentInstitutions 0.12%
Short Ratio help_outline 8.49%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.214
Price To Book help_outline 9.39
earningsQuarterlyGrowth
netIncomeToCommon -16.73M
trailingEps -1.16%
forwardEps -1.55%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.2 3Q 2024
institutionsCount 29
lastUpdated Sept. 16, 2024, 8:25 p.m.